Aviance Capital Partners LLC Has $6.15 Million Stock Position in The Procter & Gamble Company (NYSE:PG)

Aviance Capital Partners LLC cut its stake in The Procter & Gamble Company (NYSE:PG) by 0.6% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 35,490 shares of the company’s stock after selling 230 shares during the period. Procter & Gamble accounts for about 0.8% of Aviance Capital Partners LLC’s investment portfolio, making the stock its 26th biggest position. Aviance Capital Partners LLC’s holdings in Procter & Gamble were worth $6,150,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also modified their holdings of the company. Acorn Creek Capital LLC boosted its stake in Procter & Gamble by 2.8% in the third quarter. Acorn Creek Capital LLC now owns 2,170 shares of the company’s stock valued at $376,000 after acquiring an additional 59 shares during the last quarter. Patrick M Sweeney & Associates Inc. boosted its holdings in Procter & Gamble by 1.1% during the third quarter. Patrick M Sweeney & Associates Inc. now owns 5,561 shares of the company’s stock worth $963,000 after buying an additional 59 shares during the last quarter. Hudson Value Partners LLC grew its position in shares of Procter & Gamble by 4.1% during the 2nd quarter. Hudson Value Partners LLC now owns 1,516 shares of the company’s stock worth $250,000 after buying an additional 60 shares during the period. Traveka Wealth LLC increased its stake in shares of Procter & Gamble by 1.7% in the 3rd quarter. Traveka Wealth LLC now owns 3,554 shares of the company’s stock valued at $616,000 after acquiring an additional 60 shares during the last quarter. Finally, Fiduciary Alliance LLC raised its position in shares of Procter & Gamble by 2.8% in the 2nd quarter. Fiduciary Alliance LLC now owns 2,261 shares of the company’s stock valued at $371,000 after acquiring an additional 61 shares during the period. 65.77% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on the stock. DZ Bank upgraded shares of Procter & Gamble from a “hold” rating to a “buy” rating and set a $190.00 price objective for the company in a report on Thursday, August 29th. TD Cowen assumed coverage on Procter & Gamble in a research note on Tuesday, July 23rd. They set a “buy” rating and a $189.00 price objective on the stock. Stifel Nicolaus boosted their target price on Procter & Gamble from $157.00 to $161.00 and gave the company a “hold” rating in a research note on Monday, July 22nd. Barclays lowered Procter & Gamble from an “overweight” rating to an “equal weight” rating and set a $163.00 price target on the stock. in a research report on Monday, September 30th. Finally, Royal Bank of Canada reiterated a “sector perform” rating and set a $164.00 price objective on shares of Procter & Gamble in a report on Monday, October 21st. Nine investment analysts have rated the stock with a hold rating, thirteen have issued a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat, Procter & Gamble has a consensus rating of “Moderate Buy” and a consensus target price of $177.00.

Procter & Gamble Price Performance

Shares of PG opened at $170.80 on Tuesday. The company has a market cap of $402.24 billion, a price-to-earnings ratio of 29.45, a PEG ratio of 3.67 and a beta of 0.42. The company has a current ratio of 0.75, a quick ratio of 0.55 and a debt-to-equity ratio of 0.50. The company’s fifty day simple moving average is $170.21 and its 200 day simple moving average is $168.45. The Procter & Gamble Company has a 1-year low of $142.50 and a 1-year high of $177.94.

Procter & Gamble (NYSE:PG) last issued its earnings results on Friday, October 18th. The company reported $1.93 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.90 by $0.03. The company had revenue of $21.74 billion for the quarter, compared to analysts’ expectations of $21.99 billion. Procter & Gamble had a net margin of 17.07% and a return on equity of 33.25%. Procter & Gamble’s quarterly revenue was down .6% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.83 EPS. On average, research analysts forecast that The Procter & Gamble Company will post 6.94 earnings per share for the current fiscal year.

Procter & Gamble Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Friday, October 18th were given a dividend of $1.0065 per share. The ex-dividend date was Friday, October 18th. This represents a $4.03 dividend on an annualized basis and a yield of 2.36%. Procter & Gamble’s dividend payout ratio (DPR) is 69.48%.

Insider Buying and Selling at Procter & Gamble

In related news, insider Susan Street Whaley sold 634 shares of Procter & Gamble stock in a transaction that occurred on Wednesday, October 2nd. The stock was sold at an average price of $171.65, for a total transaction of $108,826.10. Following the completion of the sale, the insider now directly owns 19,341 shares of the company’s stock, valued at approximately $3,319,882.65. This trade represents a 3.17 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CEO Ma. Fatima Francisco sold 96,000 shares of the stock in a transaction on Thursday, August 22nd. The stock was sold at an average price of $170.00, for a total value of $16,320,000.00. Following the transaction, the chief executive officer now owns 13,721 shares in the company, valued at $2,332,570. The trade was a 87.49 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 270,727 shares of company stock worth $46,014,037 over the last ninety days. Insiders own 0.18% of the company’s stock.

Procter & Gamble Profile

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.